1 report

  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2017
  • VXC-486 - DRUG PROFILE
  • Tuberculosis
  • United States
  • World
  • Product Initiative
  • Spero Therapeutics, LLC